Arjuna Capital
CVS icon

Arjuna Capital’s CVS Health CVS Stock Holding History

Arjuna Capital’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.78M Sell
20,819
-143
-0.7% -$14K 0.4% 61
2026
Q2 		$2.17M Sell
20,962
-471
-2% -$42K 0.49% 57
2026
Q1 		$1.54M Buy
21,433
+581
+3% +$44.8K 0.39% 63
2025
Q4 		$1.65M Sell
20,852
-84
-0.4% -$6.62K 0.41% 61
2025
Q3 		$1.58M Buy
+20,936
New +$1.43M 0.39% 63
2024
Q4 		– Sell
-6,206
Closed -$390K – 103
2024
Q3 		$390K Sell
6,206
-54,208
-90% -$3.16M 0.1% 84
2024
Q2 		$3.57M Buy
60,414
+1,143
+2% +$71.5K 0.96% 32
2024
Q1 		$4.73M Buy
59,271
+2,204
+4% +$168K 1.34% 26
2023
Q4 		$4.51M Buy
57,067
+16,683
+41% +$1.19M 1.41% 22
2023
Q3 		$2.82M Buy
40,384
+1,051
+3% +$74.5K 1.01% 29
2023
Q2 		$2.72M Buy
39,333
+20,394
+108% +$1.45M 0.96% 32
2023
Q1 		$1.41M Sell
18,939
-25,910
-58% -$2.17M 0.55% 51
2022
Q4 		$4.18M Buy
44,849
+615
+1% +$59.3K 1.93% 13
2022
Q3 		$4.22M Buy
44,234
+14
+0% +$1.39K 2.07% 14
2022
Q2 		$4.1M Buy
44,220
+1,431
+3% +$140K 1.98% 18
2022
Q1 		$4.33M Buy
42,789
+2,983
+7% +$313K 1.81% 17
2021
Q4 		$4.11M Buy
39,806
+1,803
+5% +$167K 1.5% 20
2021
Q3 		$3.22M Buy
38,003
+10,782
+40% +$903K 1.31% 23
2021
Q2 		$2.27M Buy
27,221
+3,678
+16% +$301K 0.98% 31
2021
Q1 		$1.77M Buy
23,543
+1,200
+5% +$87.4K 0.87% 38
2020
Q4 		$1.53M Buy
22,343
+1,017
+5% +$66.1K 0.84% 39
2020
Q3 		$1.24M Buy
21,326
+423
+2% +$26.3K 0.77% 42
2020
Q2 		$1.36M Buy
20,903
+623
+3% +$39.2K 0.94% 38
2020
Q1 		$1.2M Buy
+20,280
New +$1.35M 1% 36
2019
Q2 		– Sell
-10,354
Closed -$558K – 96
2019
Q1 		$558K Sell
10,354
-498
-5% -$30.7K 0.43% 65
2018
Q4 		$711K Buy
10,852
+149
+1% +$11.1K 0.65% 50
2018
Q3 		$843K Buy
10,703
+1,902
+22% +$136K 0.63% 52
2018
Q2 		$566K Buy
+8,801
New +$580K 0.46% 63

Other funds holding CVS

Pzena Investment Management
Pzena Investment Management New York $34.1B AUM 26.62% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $194B AUM 32.2% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $84.4B AUM 20.16% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

Arjuna Capital's CVS Position: Q3 2026 in Review

Arjuna Capital reduced its CVS Health (CVS) stake by 0.68% in Q3 2026, selling an estimated $14K and leaving 20,819 shares worth $1.78M. The position accounts for 0.4% of the portfolio, ranked #61.

Arjuna Capital first reported a position in CVS in Q2 2018 and has held it in 28 quarters since. The position peaked at $4.73M in Q1 2024. 1,069 funds tracked by Wall St. Rank hold CVS as of Q3 2026.

  • Arjuna Capital held 20,819 shares of CVS Health worth $1.78M as of Q3 2026.
  • Arjuna Capital sold 143 CVS Health shares in Q3 2026, an estimated $14K.
  • CVS Health made up 0.4% of Arjuna Capital's portfolio in Q3 2026, its #61 holding.
  • Arjuna Capital first reported a position in CVS Health in Q2 2018 and has held it in 28 quarters since.
  • Arjuna Capital's CVS Health position peaked at $4.73M in Q1 2024.
  • 1,069 funds tracked by Wall St. Rank held CVS Health as of Q3 2026.

Based on Arjuna Capital's 13F filing for Q3 2026, filed 3 Nov 2026.